{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:16:31Z","timestamp":1791389791864,"version":"4.3.3"},"reference-count":134,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.jaci.2011.09.005","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T15:10:43Z","timestamp":1319814643000},"page":"1139-1150.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":468,"title":["Histamine and H1-antihistamines: Celebrating a century of progress"],"prefix":"10.1016","volume":"128","author":[{"given":"F. Estelle R.","family":"Simons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith J.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2011.09.005_bib1","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMra033121","article-title":"Advances in H1-antihistamines","volume":"351","author":"Simons","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.09.005_bib2","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1002\/cber.190704003164","article-title":"Synthese des imidazolylethylamines","volume":"3","author":"Windaus","year":"1907","journal-title":"Ber Dtsch Chem Ges"},{"key":"10.1016\/j.jaci.2011.09.005_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1113\/jphysiol.1910.sp001406","article-title":"The physiological action of beta-iminazolylethylamine","volume":"41","author":"Dale","year":"1910","journal-title":"J Physiol"},{"key":"10.1016\/j.jaci.2011.09.005_bib4","first-page":"527","article-title":"Action protectrice des \u00e9thers ph\u00e9noliques au cours de l\u2019intoxication histaminique","volume":"124","author":"Bovet","year":"1937","journal-title":"CRS Soc Biol (Paris)"},{"key":"10.1016\/j.jaci.2011.09.005_bib5","first-page":"339","article-title":"Les antihistaminiques de synth\u00e8se: essai de chimioth\u00e9rapie des \u00e9tats allergiques","volume":"68","author":"Halpern","year":"1942","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.jaci.2011.09.005_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-3565(25)07849-8","article-title":"The anti-histamine properties of Benadryl, \u03b2-dimethylaminoethyl benzhydryl ether hydrochloride","volume":"86","author":"Loew","year":"1946","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2011.09.005_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.1951.02920230001001","article-title":"The toxic effects of antihistaminic drugs","volume":"145","author":"Wyngaarden","year":"1951","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2011.09.005_bib8","first-page":"47P","article-title":"Histamine release by antihistamines","volume":"119","author":"Arunlakshana","year":"1953","journal-title":"J Physiol"},{"key":"10.1016\/j.jaci.2011.09.005_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/030006058000800607","article-title":"A double-blind trial of terfenadine and placebo in hay fever using a substitution technique for non-responders","volume":"8","author":"Kagan","year":"1980","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jaci.2011.09.005_bib10","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1073\/pnas.81.8.2572","article-title":"Histamine-containing neurons in the rat hypothalamus","volume":"81","author":"Panula","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2011.09.005_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1073\/pnas.88.2.429","article-title":"Molecular cloning of a gene encoding the histamine H2 receptor","volume":"88","author":"Gantz","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2011.09.005_bib12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1006\/bbrc.1993.2662","article-title":"Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor","volume":"197","author":"De Backer","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2011.09.005_bib13","first-page":"1101","article-title":"Cloning and functional expression of the human histamine H3 receptor","volume":"55","author":"Lovenberg","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib14","doi-asserted-by":"crossref","first-page":"36781","DOI":"10.1074\/jbc.M006480200","article-title":"Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes","volume":"275","author":"Oda","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2011.09.005_bib15","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/S0014-2999(99)00803-1","article-title":"Constitutive activity of the histamine H1 receptor reveals inverse agonism of histamine H1 receptor antagonists","volume":"387","author":"Bakker","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1124\/mol.60.5.1133","article-title":"Histamine H1-receptor activation of nuclear factor-\u03baB: roles for G\u03b2\u03b3- and G\u03b1q\/11-subunits in constitutive and agonist-mediated signaling","volume":"60","author":"Bakker","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tips.2011.02.004","article-title":"En route to new blockbuster antihistamines: surveying the offspring of the expanding histamine receptor family","volume":"32","author":"Leurs","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jaci.2011.09.005_bib18","series-title":"Middleton\u2019s allergy: principles and practice","first-page":"1517","article-title":"Histamine and H1-antihistamines","author":"Simons","year":"2009"},{"key":"10.1016\/j.jaci.2011.09.005_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","article-title":"Histamine in the nervous system","volume":"88","author":"Haas","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jaci.2011.09.005_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.smrv.2010.06.004","article-title":"Histamine in the regulation of wakefulness","volume":"15","author":"Thakkar","year":"2011","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jaci.2011.09.005_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/B978-0-12-381298-8.00007-1","article-title":"Constitutive activity of the histamine H(1) receptor","volume":"484","author":"Nijmeijer","year":"2010","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jaci.2011.09.005_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature10236","article-title":"Structure of the human histamine H1 receptor complex with doxepin","volume":"475","author":"Shimamura","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2011.09.005_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00003495-200767030-00008","article-title":"Rupatadine: a review of its use in the management of allergic disorders","volume":"67","author":"Keam","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2011.09.005_bib24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1365-2133.2010.10029.x","article-title":"Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex\u00a0vivo platelet aggregation in healthy males","volume":"163","author":"Church","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2011.09.005_bib25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00011-009-0117-4","article-title":"The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber","volume":"59","author":"Horak","year":"2010","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jaci.2011.09.005_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.anai.2010.06.008","article-title":"Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device","volume":"105","author":"Hampel","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib27","first-page":"11","article-title":"Bepotastine (Bepreve)\u2014an ophthalmic H1-antihistamine","volume":"52","year":"2010","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/j.jaci.2011.09.005_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/jop.2010.0153","article-title":"Clinical pharmacology of alcaftadine, a novel antihistamine for the prevention of allergic conjunctivitis","volume":"27","author":"Bohets","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jaci.2011.09.005_bib29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/ACI.0b013e3283303ebb","article-title":"Multiple action agents and the eye: do they really stabilize mast cells?","volume":"9","author":"Lambiase","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib30","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/jid.2009.134","article-title":"Desloratadine inhibits human skin mast cell activation and histamine release","volume":"129","author":"Weller","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2011.09.005_bib31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1517\/14740338.2011.562889","article-title":"Positron emission tomography evaluation of sedative properties of antihistamines","volume":"10","author":"Yanai","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaci.2011.09.005_bib32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/JCP.0b013e3181fa8526","article-title":"Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography","volume":"30","author":"Zhang","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1398-9995.2009.02325.x","article-title":"Risk of first-generation H1-antihistamines: a GA2LEN position paper","volume":"65","author":"Church","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.09.005_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00003088-200847040-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine: a comparative review","volume":"47","author":"Devillier","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaci.2011.09.005_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1517\/17425250903382615","article-title":"Clinical pharmacokinetics of fexofenadine enantiomers","volume":"6","author":"Miura","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jaci.2011.09.005_bib36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2010.03722.x","article-title":"Fruit juice inhibition of uptake transport: a new type of food-drug interaction","volume":"70","author":"Bailey","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib37","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2165\/9884960-000000000-00000","article-title":"Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast","volume":"69","author":"Phan","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2011.09.005_bib38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1081-1206(10)60470-X","article-title":"Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine","volume":"100","author":"Jones","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2125.2007.03009.x","article-title":"Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine","volume":"65","author":"Frossard","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2500\/aap.2009.30.3226","article-title":"The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines","volume":"30","author":"Gillman","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2011.09.005_bib41","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.jaci.2007.02.048","article-title":"Relevance of H1-receptor occupancy to antihistamine dosing in children","volume":"119","author":"Simons","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib42","first-page":"9","article-title":"Drugs for allergic disorders","volume":"9","year":"2010","journal-title":"Treat Guide Med Lett"},{"key":"10.1016\/j.jaci.2011.09.005_bib43","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision","volume":"126","author":"Brozek","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.iac.2011.05.003","article-title":"Antihistamine therapy in allergic rhinitis","volume":"31","author":"Hoyte","year":"2011","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2011.09.005_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2222.2007.02888.x","article-title":"BSACI guidelines for the management of allergic and non-allergic rhinitis","volume":"38","author":"Scadding","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"suppl","key":"10.1016\/j.jaci.2011.09.005_bib46","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.iac.2007.12.005","article-title":"Allergic conjunctivitis","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2011.09.005_bib48","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1398-9995.2009.02178.x","article-title":"EAACI\/GA2LEN\/EDF\/WAO guideline: management of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.09.005_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-3038.2010.01120.x","article-title":"Chronic spontaneous urticaria in children: itching for insight","volume":"22","author":"Church","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000316351","article-title":"Efficacy of desloratadine in persistent allergic rhinitis\u2014a GA2LEN study","volume":"153","author":"Bousquet","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib51","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1185\/03007990802395927","article-title":"Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A\u00a0pilot study","volume":"24","author":"Canonica","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2011.09.005_bib52","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.clinthera.2009.05.017","article-title":"A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis","volume":"31","author":"Bachert","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaci.2011.09.005_bib53","first-page":"117","article-title":"Efficacy and safety of desloratadine\/pseudoephedrine combination vs its components in seasonal allergic rhinitis","volume":"19","author":"Grubbe","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.anai.2009.11.020","article-title":"Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class","volume":"104","author":"Benninger","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib55","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1185\/03007990902875992","article-title":"Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective","volume":"25","author":"Hay","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2011.09.005_bib56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1513\/pats.201004-033RN","article-title":"Overview of the treatment of allergic rhinitis and nonallergic rhinopathy","volume":"8","author":"Greiner","year":"2011","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jaci.2011.09.005_bib57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2009.06.027","article-title":"Unmet needs in severe chronic upper airway disease (SCUAD)","volume":"124","author":"Bousquet","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2011.09.005_bib58","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.anai.2010.08.010","article-title":"The efficacy of intranasal antihistamines in the treatment of allergic rhinitis","volume":"106","author":"Kaliner","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clinthera.2009.01.016","article-title":"Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults","volume":"31","author":"Shah","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaci.2011.09.005_bib60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2500\/aap.2011.32.3439","article-title":"Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis","volume":"32","author":"Lieberman","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2011.09.005_bib61","first-page":"87","article-title":"Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%","volume":"5","author":"Greiner","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jaci.2011.09.005_bib62","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.clinthera.2009.09.001","volume":"31","author":"Abelson","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaci.2011.09.005_bib63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.anai.2010.04.005","article-title":"Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge","volume":"105","author":"Torkildsen","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1081-1206(10)60662-X","article-title":"H1-antihistamine treatment in young atopic children: effect on urticaria","volume":"99","author":"Simons","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib65","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1398-9995.2008.01893.x","article-title":"Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients","volume":"64","author":"Potter","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.09.005_bib66","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1468-3083.2009.03289.x","article-title":"The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg","volume":"23","author":"Gimenez-Arnau","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2011.09.005_bib67","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1398-9995.2009.02217.x","article-title":"Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study","volume":"65","author":"Zuberbier","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.09.005_bib68","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2009.11.047","article-title":"The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria","volume":"125","author":"Staevska","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib69","article-title":"Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses","author":"Zuberbier","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2011.09.005_bib70","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jaci.2008.12.008","article-title":"High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study","volume":"123","author":"Siebenhaar","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib71","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.anai.2009.11.013","article-title":"Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria","volume":"104","author":"Metz","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria. A\u00a0GA2LEN task force report","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.09.005_bib73","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/ehm.10.42","article-title":"Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives","volume":"3","author":"Arock","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jaci.2011.09.005_bib74","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2340\/00015555-0085","article-title":"Levocetirizine for treatment of immediate and delayed mosquito bite reactions","volume":"86","author":"Karppinen","year":"2006","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/j.jaci.2011.09.005_bib75","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaci.2008.08.007","article-title":"Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy","volume":"122","author":"Muller","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4419-8056-4_8","article-title":"Histamine and antihistamines in atopic dermatitis","volume":"709","author":"Buddenkotte","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaci.2011.09.005_bib77","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4419-8056-4_6","article-title":"The role of histamine in asthma","volume":"709","author":"Dunford","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaci.2011.09.005_bib78","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1398-9995.2007.01435.x","article-title":"H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review","volume":"62","author":"Sheikh","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.09.005_bib79","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1213\/ANE.0b013e3181d7ac98","article-title":"Hereditary angioedema: current and emerging treatment options","volume":"110","author":"Levy","year":"2010","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.jaci.2011.09.005_bib80","first-page":"CD001727","article-title":"Decongestants and antihistamines for acute otitis media in children","author":"Coleman","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2011.09.005_bib81","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4065\/mcp.2010.0392","article-title":"Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines","volume":"86","author":"Meltzer","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.jaci.2011.09.005_bib82","first-page":"CD007909","article-title":"Decongestants, antihistamines and nasal irrigation for acute sinusitis in children","author":"Shaikh","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jaci.2011.09.005_bib83","first-page":"CD005604","article-title":"Antihistamines for prolonged non-specific cough in children","author":"Chang","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2011.09.005_bib84","unstructured":"Williamson I. Otitis media with effusion in children. Clin Evid (Online) 2011; pii:\u00a00502."},{"key":"10.1016\/j.jaci.2011.09.005_bib85","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11882-010-0117-z","article-title":"Pathogenesis and treatment of pruritus","volume":"10","author":"Greaves","year":"2010","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2011.09.005_bib86","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/sleep\/33.11.1553","article-title":"Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia","volume":"33","author":"Krystal","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.jaci.2011.09.005_bib87","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00246-009-9622-z","article-title":"Moderate sedation for echocardiography of preschoolers","volume":"31","author":"Roach","year":"2010","journal-title":"Pediatr Cardiol"},{"issue":"12","key":"10.1016\/j.jaci.2011.09.005_bib88","first-page":"CD006815","article-title":"Hydroxyzine for generalised anxiety disorder","author":"Guaiana","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2011.09.005_bib89","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/EJA.0b013e32833f53b8","article-title":"Antiemetic efficacy of metoclopramide and diphenhydramine added to patient-controlled morphine analgesia: a randomised controlled trial","volume":"27","author":"Lu","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jaci.2011.09.005_bib90","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMcp1003896","article-title":"Clinical practice. Nausea and vomiting in pregnancy","volume":"363","author":"Niebyl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.09.005_bib91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00019052-200502000-00007","article-title":"Motion sickness","volume":"18","author":"Golding","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jaci.2011.09.005_bib92","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/oby.2010.176","article-title":"Association of prescription H1 antihistamine use with obesity: results from the National Health\u00a0and Nutrition Examination Survey","volume":"18","author":"Ratliff","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jaci.2011.09.005_bib93","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3357\/ASEM.2888.2011","article-title":"Effects of promethazine and midodrine on orthostatic tolerance","volume":"82","author":"Shi","year":"2011","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.jaci.2011.09.005_bib94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archsurg.2009.258","article-title":"Influence of histamine receptor antagonists on the outcome of perforated appendicitis: analysis from a prospective trial","volume":"145","author":"St Peter","year":"2010","journal-title":"Arch Surg"},{"key":"10.1016\/j.jaci.2011.09.005_bib95","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000321614","article-title":"Effects of antihistamines on innate immune responses to severe bacterial infection in mice","volume":"155","author":"Metz","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hup.1184","article-title":"Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratio","volume":"26","author":"Kubo","year":"2011","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib97","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/hup.1051","article-title":"Dose dependency of brain histamine H(1) receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with 11C-doxepin","volume":"24","author":"Tashiro","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib98","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2125.2008.03143.x","article-title":"Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin","volume":"65","author":"Tashiro","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib99","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.scijus.2009.09.016","article-title":"Trends in drug use of Scottish drivers arrested under Section 4 of the Road Traffic Act\u2014a 10 year review","volume":"49","author":"Officer","year":"2009","journal-title":"Sci Justice"},{"key":"10.1016\/j.jaci.2011.09.005_bib100","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.aap.2010.07.004","article-title":"The prevalence of drugs in motor vehicle accidents and traffic violations in Shanghai and neighboring cities","volume":"42","author":"Zhuo","year":"2010","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.jaci.2011.09.005_bib101","first-page":"514","article-title":"First-generation H1 antihistamines found in pilot fatalities of civil aviation accidents, 1990-2005","volume":"78","author":"Sen","year":"2007","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.jaci.2011.09.005_bib102","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1185\/030079906X112660","article-title":"Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects","volume":"22","author":"Boyle","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2011.09.005_bib103","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hup.962","article-title":"Sedation and antihistamines: an update. Review of inter-drug differences using proportional impairment ratios","volume":"23","author":"McDonald","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib104","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/JCP.0b013e318218943c","article-title":"Short-term effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy volunteers","volume":"31","author":"Conen","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/0269881107083809","article-title":"Diphenhydramine abuse and detoxification: a brief review and case report","volume":"23","author":"Thomas","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib106","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2215\/CJN.01090210","article-title":"Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials","volume":"5","author":"Kurella Tamura","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jaci.2011.09.005_bib107","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1553-2712.2010.00667.x","article-title":"Potentially inappropriate medication utilization in the emergency department visits by older adults: analysis from a nationally representative sample","volume":"17","author":"Meurer","year":"2010","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jaci.2011.09.005_bib108","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/gps.2569","article-title":"Medical conditions and medications as risk factors of falls in the inpatient older people: a case-control study","volume":"26","author":"Chang","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jaci.2011.09.005_bib109","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/sleep\/29.7.957","article-title":"Characterizing impaired functional alertness from diphenhydramine in the elderly with performance and neurophysiologic measures","volume":"29","author":"McEvoy","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.jaci.2011.09.005_bib110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.reprotox.2008.05.053","article-title":"The safety of cetirizine during pregnancy. A\u00a0prospective observational cohort study","volume":"26","author":"Weber-Schoendorfer","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jaci.2011.09.005_bib111","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2165\/00002018-200831090-00006","article-title":"Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis","volume":"31","author":"Schwarz","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaci.2011.09.005_bib112","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pediatrneurol.2009.11.001","article-title":"Seizure susceptibility due to antihistamines in febrile seizures","volume":"42","author":"Takano","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jaci.2011.09.005_bib113","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1517\/14740330903496410","article-title":"Safety and efficacy of over-the-counter cough and cold medicines for use in children","volume":"9","author":"Vassilev","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaci.2011.09.005_bib114","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1542\/peds.2010-1839","article-title":"Adverse events from cough and cold medications after a market withdrawal of products labeled for infants","volume":"126","author":"Shehab","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2011.09.005_bib115","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1542\/peds.2007-3813","article-title":"Unexpected infant deaths associated with use of cough and cold medications","volume":"122","author":"Rimsza","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2011.09.005_bib116","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.annemergmed.2008.09.015","article-title":"Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications","volume":"53","author":"Dart","year":"2009","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaci.2011.09.005_bib117","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/PAF.0b013e31819df748","article-title":"Death of a child from topical diphenhydramine","volume":"30","author":"Turner","year":"2009","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.jaci.2011.09.005_bib118","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00228-010-0875-5","article-title":"Torsades de pointes tachycardia induced by common cold compound medication containing chlorpheniramine","volume":"66","author":"Nia","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib119","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jat.1252","article-title":"Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656","volume":"28","author":"Park","year":"2008","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.jaci.2011.09.005_bib120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.phrs.2009.05.008","article-title":"H(1) antihistamine drug promethazine directly blocks hERG K(+) channel","volume":"60","author":"Jo","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jaci.2011.09.005_bib121","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/15563650.2010.514269","article-title":"Diphenhydramine dose-response: a novel approach to determine triage thresholds","volume":"48","author":"Benson","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jaci.2011.09.005_bib122","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3109\/15563650.2010.497149","article-title":"Validation of the American Association of Poison Control Centers out of hospital guideline for pediatric diphenhydramine ingestions","volume":"48","author":"Sugyani Bebarta","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jaci.2011.09.005_bib123","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2125.2010.03648.x","article-title":"Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study","volume":"69","author":"Garcia-Gea","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib124","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00228-007-0366-5","article-title":"Levocetirizine does not prolong the QT\/QTc interval in healthy subjects: results from a thorough QT study","volume":"63","author":"Hulhoven","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.2009.03599.x","article-title":"No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a \u201cthorough QT\/QTc study\u201d performed according to ICH guidelines","volume":"69","author":"Donado","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib126","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-3038.2007.00558.x","article-title":"Safety of levocetirizine treatment in young atopic children: an 18-month study","volume":"18","author":"Simons","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib127","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1517\/13543776.2010.510516","article-title":"The expanding role of H1 antihistamines: a patent survey of selective and dual activity compounds 2005-2010","volume":"20","author":"Beaton","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.jaci.2011.09.005_bib128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4419-8056-4_12","article-title":"The future antihistamines: histamine H3 and H4 receptor ligands","volume":"709","author":"Yu","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaci.2011.09.005_bib129","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/13543776.2010.509346","article-title":"Recent advances in histamine H3 receptor antagonists\/inverse agonists","volume":"20","author":"Lazewska","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.jaci.2011.09.005_bib130","doi-asserted-by":"crossref","first-page":"AB191","DOI":"10.1016\/j.jaci.2009.12.750","article-title":"The effects of an H3 receptor antagonist in a nasal allergen challenge model","volume":"125","author":"Romero","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.09.005_bib131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11882-008-0005-y","article-title":"The new biology of histamine receptors","volume":"8","author":"Huang","year":"2008","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2011.09.005_bib132","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1465-9921-11-86","article-title":"Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines","volume":"11","author":"Cowden","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2011.09.005_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.06.029","article-title":"The histamine H4 receptor: Targeting inflammatory disorders","volume":"668","author":"Walter","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2011.09.005_bib134","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1476-5381.2009.00151.x","article-title":"The role of histamine H4 receptor in immune and inflammatory disorders","volume":"157","author":"Zampeli","year":"2009","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911014084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911014084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:30:02Z","timestamp":1758789002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911014084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":134,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0091674911014084"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.09.005","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histamine and H1-antihistamines: Celebrating a century of progress","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}